These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1910463)

  • 1. Insulin analogues with modifications in the beta-turn of the B-chain.
    Wang SH; Hu SQ; Burke GT; Katsoyannis PG
    J Protein Chem; 1991 Jun; 10(3):313-24. PubMed ID: 1910463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steric requirements at position B12 for high biological activity in insulin.
    Hu SQ; Burke GT; Schwartz GP; Ferderigos N; Ross JB; Katsoyannis PG
    Biochemistry; 1993 Mar; 32(10):2631-5. PubMed ID: 8448120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
    Chu YC; Zong L; Burke GT; Katsoyannis PG
    J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
    Burke GT; Schwartz G; Katsoyannis PG
    Int J Pept Protein Res; 1984 Apr; 23(4):394-401. PubMed ID: 6373642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin.
    Schwartz GP; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1983 Sep; 22(19):4561-7. PubMed ID: 6354263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 1. [21-Desasparagine,20-cysteinamide-A]insulin and [21-desasparagine,20-cysteine isopropylamide-A]insulin.
    Chu YC; Wang RY; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1987 Nov; 26(22):6966-71. PubMed ID: 3322393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of an insulin-like compound consisting of the A chain of insulin and a B chain corresponding to the B domain of human insulin-like growth factor I.
    Joshi S; Burke GT; Katsoyannis PG
    Biochemistry; 1985 Jul; 24(15):4208-14. PubMed ID: 3902081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A]insulin.
    Ohta N; Burke GT; Katsoyannis PG
    J Protein Chem; 1988 Feb; 7(1):55-65. PubMed ID: 3076448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of N-methylation of selected peptide bonds on the biological activity of insulin. [2-N-methylisoleucine-A]insulin and [3-N-methylvaline-A]insulin.
    Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
    Int J Pept Protein Res; 1987 Oct; 30(4):460-73. PubMed ID: 3323092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of seventeen analogues of human insulin.
    Märki F; de Gasparo M; Eisler K; Kamber B; Riniker B; Rittel W; Sieber P
    Hoppe Seylers Z Physiol Chem; 1979 Nov; 360(11):1619-32. PubMed ID: 511097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the B16 and B26 tyrosine residues to the biological activity of insulin.
    Hu SQ; Burke GT; Katsoyannis PG
    J Protein Chem; 1993 Dec; 12(6):741-7. PubMed ID: 8136024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of growth-promoting activity reside in the A-domain of insulin-like growth factor I.
    Chen ZZ; Schwartz GP; Zong L; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1988 Aug; 27(16):6105-11. PubMed ID: 3056519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An insulin-like hybrid consisting of a modified A-domain of human insulin-like growth factor I and the B-chain of insulin.
    Zong L; Burke GT; Katsoyannis PG
    J Protein Chem; 1990 Aug; 9(4):389-95. PubMed ID: 2275749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A highly potent insulin: des-(B26-B30)-[AspB10,TyrB25-NH2]insulin(human).
    Schwartz GP; Burke GT; Katsoyannis PG
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):458-61. PubMed ID: 2643113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoaffinity labeling of insulin receptor with an insulin analogue selectively modified at the amino terminal of the B chain.
    Yeung CW; Moule ML; Yip CC
    Biochemistry; 1980 May; 19(10):2196-203. PubMed ID: 6990974
    [No Abstract]   [Full Text] [Related]  

  • 16. Critical role of the A2 amino acid residue in the biological activity of insulin: [2-glycine-A]- and [2-alanine-A]insulins.
    Kitagawa K; Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1984 Mar; 23(7):1405-13. PubMed ID: 6372857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chiral mutagenesis of insulin. Foldability and function are inversely regulated by a stereospecific switch in the B chain.
    Nakagawa SH; Zhao M; Hua QX; Hu SQ; Wan ZL; Jia W; Weiss MA
    Biochemistry; 2005 Apr; 44(13):4984-99. PubMed ID: 15794637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions.
    Nakagawa SH; Tager HS
    Biochemistry; 1992 Mar; 31(12):3204-14. PubMed ID: 1554705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 3. [21-Desasparagine,20-cysteine ethylamide-A]insulin and [21-desasparagine,20-cysteine 2,2,2-trifluoroethylamide-A]insulin.
    Chu YC; Wang RY; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1987 Nov; 26(22):6975-9. PubMed ID: 3322395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [B22-D-arginine]insulin: synthesis and biological properties.
    Knorr R; Danho W; Büllesbach EE; Gattner HG; Zahn H; King GL; Kahn CR
    Hoppe Seylers Z Physiol Chem; 1982 Dec; 363(12):1449-60. PubMed ID: 6761262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.